【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Vision Care Overview 13
3 Products under Development 15
3.1 Vision Care – Pipeline Products by Stage of Development 15
3.2 Vision Care – Pipeline Products by Segment 16
3.3 Vision Care – Pipeline Products by Territory 17
3.4 Vision Care – Pipeline Products by Regulatory Path 18
3.5 Vision Care – Pipeline Products by Estimated Approval Date 19
3.6 Vision Care – Ongoing Clinical Trials 20
4 Vision Care – Pipeline Products under Development by Companies 21
4.1 Vision Care Companies – Pipeline Products by Stage of Development 21
4.2 Vision Care – Pipeline Products by Stage of Development 24
5 Vision Care Companies and Product Overview 27
5.1 Adventus Technology Inc Company Overview 27
5.1.1 Adventus Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Alcon, Inc. Company Overview 28
5.2.1 Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Apeliotus Ophthalmics Company Overview 32
5.3.1 Apeliotus Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Auburn University Company Overview 34
5.4.1 Auburn University Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Axcelon Biopolymers Corp. Company Overview 35
5.5.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 Bar-Ilan University Company Overview 36
5.6.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Bausch & Lomb Incorporated Company Overview 38
5.7.1 Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview 38
5.8 Belfanti – Fureder – Meidl technisches Buro f Elektro u Haustechnik GmbH Company Overview 42
5.8.1 Belfanti – Fureder – Meidl technisches Buro f Elektro u Haustechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 Bionic Vision Australia Company Overview 43
5.9.1 Bionic Vision Australia Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Body Organ Biomedical Corp. Company Overview 48
5.10.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Children’s Hospital Boston Company Overview 50
5.11.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 50
5.12 Consejo Superior de Investigaciones Cientificas Company Overview 51
5.12.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 51
5.13 CooperVision, Inc. Company Overview 53
5.13.1 CooperVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.14 Cornell University Company Overview 54
5.14.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 EP Global Communications, Inc. Company Overview 55
5.15.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.16 eSight Corporation Company Overview 56
5.16.1 eSight Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
5.17 Euclid Systems Corporation Company Overview 57
5.17.1 Euclid Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 57
5.18 Eyegenix Company Overview 58
5.18.1 Eyegenix Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 EyeNetra, Inc. Company Overview 59
5.19.1 EyeNetra, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.20 Eyenovations Company Overview 60
5.20.1 Eyenovations Pipeline Products & Ongoing Clinical Trials Overview 60
5.21 EyeYon Medical Company Overview 61
5.21.1 EyeYon Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.22 Imperial College London Company Overview 65
5.22.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 65
5.23 iSTAR Medical Company Overview 66
5.23.1 iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 66
5.24 Johnson & Johnson Vision Care, Inc. Company Overview 67
5.24.1 Johnson & Johnson Vision Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.25 Massachusetts Eye and Ear Infirmary Company Overview 72
5.25.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 72
5.26 Medisse BV Company Overview 73
5.26.1 Medisse BV Pipeline Products & Ongoing Clinical Trials Overview 73
5.27 Mercy Research and Development Company Overview 74
5.27.1 Mercy Research and Development Pipeline Products & Ongoing Clinical Trials Overview 74
5.28 Microbiosensor Ltd Company Overview 76
5.28.1 Microbiosensor Ltd Pipeline Products & Ongoing Clinical Trials Overview 76
5.29 Monash University Company Overview 77
5.29.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview 77
5.30 Nano Retina, Inc. Company Overview 79
5.30.1 Nano Retina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.31 Novartis AG Company Overview 80
5.31.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 80
5.32 Ocular Dynamics, LLC Company Overview 83
5.32.1 Ocular Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.33 Ocutec Limited Company Overview 84
5.33.1 Ocutec Limited Pipeline Products & Ongoing Clinical Trials Overview 84
5.34 PixelOptics, Inc. Company Overview 85
5.34.1 PixelOptics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.35 Pixium Vision Company Overview 86
5.35.1 Pixium Vision Pipeline Products & Ongoing Clinical Trials Overview 86
5.36 Presbia Plc Company Overview 87
5.36.1 Presbia Plc Pipeline Products & Ongoing Clinical Trials Overview 87
5.37 Queensland University of Technology Company Overview 90
5.37.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 90
5.38 ReVision Optics, Inc. Company Overview 91
5.38.1 ReVision Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 91
5.39 Stanford University Company Overview 95
5.39.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 95
5.40 Tel Aviv University Company Overview 96
5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 96
5.41 The Hong Kong University of Science and Technology Company Overview 97
5.41.1 The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 97
5.42 The Johns Hopkins University Company Overview 98
5.42.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 98
5.43 UltraVision CLPL Company Overview 100
5.43.1 UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview 100
5.44 University of Auckland Company Overview 101
5.44.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 101
5.45 University of California, San Diego Company Overview 103
5.45.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 103
5.46 University of Florida Company Overview 105
5.46.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 105
5.47 University of Oxford Company Overview 106
5.47.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 106
5.48 University of Rochester Company Overview 108
5.48.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 108
5.49 University of Tennessee, Knoxville Company Overview 110
5.49.1 University of Tennessee, Knoxville Pipeline Products & Ongoing Clinical Trials Overview 110
5.50 University of Valencia Company Overview 112
5.50.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 112
5.51 University of Washington Company Overview 114
5.51.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 114
5.52 Visioneering Technologies, Inc. Company Overview 117
5.52.1 Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.53 VISTAKON Pharmaceuticals, LLC Company Overview 123
5.53.1 VISTAKON Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.54 Visual Pathways, Inc. (Inactive) Company Overview 124
5.54.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 124
5.55 Visus Technology, Inc. Company Overview 126
5.55.1 Visus Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
5.56 Yolia Health Company Overview 127
5.56.1 Yolia Health Pipeline Products & Ongoing Clinical Trials Overview 127
5.57 Ziemer Ophthalmic Systems AG Company Overview 128
5.57.1 Ziemer Ophthalmic Systems AG Pipeline Products & Ongoing Clinical Trials Overview 128
5.58 ZircLight Inc. Company Overview 129
5.58.1 ZircLight Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
6 Vision Care- Recent Developments 131
7 Appendix 210
7.1 Methodology 210
7.2 About GlobalData 212
7.3 Contact Us 213
7.4 Disclaimer 213
【レポート販売概要】
■ タイトル：世界のビジョンケア機器開発動向：医療機器パイプライン分析2015■ 英文：Vision Care - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0135EPD
■ 調査対象地域：グローバル
- Laerdal Medical AS：市場シェア分析Laerdal Medical AS Market Share Analysis Summary GlobalData’s new report, “Laerdal Medical AS Market Share Analysis” provides in-depth information on Laerdal Medical AS’s market position in the different medical equipment markets it operates in. The report provides Laerdal Medical AS market share information in two key market categories – Respiratory Disposables and Respiratory Devices. The report …
- デスクトップ仮想化（VDI）の世界市場2017-2021About Virtual Desktop Infrastructure A virtual desktop infrastructure (VDI) solution can be considered a platform in which a client server is employed to access a user system virtually. This type of computing model makes use of a centralized storage space, where data and system applications are stored centrally on the server. End-users have to enter their login details to gain remote access to the …
- 世界のスーパーグリッド市場2015The Global Super Grid Industry Report 2015 is a professional and in-depth study on the current state of the Super Grid industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Super Grid market analysis is provided for the international markets including development trends, competitive landscape analysis, a …
- 世界のモジュラーADC（アプリケーション・デリバリ・コントローラ）市場動向（2012-2016）TechNavio's analysts forecast the Global Modular Application Delivery Controller (ADC) market to grow at a CAGR of 6.87 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapid growth of network traffic. The Global Modular ADC market has also been witnessing an increasing consolidation of enterprise networks. However, vendors’ high dependency on com …
- やし油の世界市場Coconut oil (CAS 8001-31-8) Market Research Report 2013 presents comprehensive data on coconut oil markets globally and regionally (Europe, Asia, North America etc.) The Coconut oil (CAS 8001-31-8) Market Research Report 2013 includes coconut oil description, covers its application areas and related patterns. It overviews coconut oil market, names coconut oil producers and indicates its suppliers. …
- 世界のセイボリースナック市場動向：企業M&A（2014年5月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global savory snacks market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global savory snacks market throughout the month. Additionally, the report provides an overview of all the …
- 低コスト衛星の世界市場2017-2021About Low-cost Satellite A satellite is an artificial object placed manually into the orbit to serve various purposes such as navigation, collection of weather information, civilian and Earth observation (EO), and research. It is a computer-controlled system that can perform tasks such as thermal control, telemetry, power generation, attitude control, and orbit control. The data collected by satel …
- 2014年戦略提言：ヨーロッパの止血診断検査市場Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.SummaryThis comprehensive five-country report contains 500 pages, 120 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing market during the next five years. The report explores bu …
- 便失禁(Anal Incontinence)：世界の治験レビュー（2015年上半期版）Anal Incontinence Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Anal Incontinence Global Clinical Trials Review, H1, 2015" provides data on the Anal Incontinence clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anal Incontinence. It includes an overview of the trial numbers and their recruitment s …
- マイクロカプセル化成分のアジア太平洋市場：色素、ビタミン、UVフィルター、美白成分、有効成分、エッセンシャルオイル、老化防止成分Microencapsulation is a process in which ingredients such as pigments, vitamins, UV filters, and others, are encapsulated to form a capsule. The Asia-Pacific microencapsulated ingredients market was valued at $120.59 million in 2018 and is estimated to reach $193.36 million by 2026, growing at a CAGR of 6.0% from 2019 to 2026. Microencapsulation is used increasingly in the skin care and personal c …
- トルクコンバータの世界市場予測（～2025年）：AT、DVT、DCT、クラッチプレート、ダンパー、インペラー、タービン、固定子、車両、ハイブリッド車、アフターマーケット、地域別分析The torque converter market, by value, is projected to grow at a CAGR of 5.78% from 2017 to 2025, to reach USD 9.88 Billion by 2025. The key factors driving the market growth include the increasing penetration of automatics in mid-segment vehicles and the increasing sale of premium segment vehicles. The rapid growth of the hybrid vehicle market is also expected to boost the demand for torque conve …
- 人工内耳（蝸牛インプラント）の世界市場2016-2020About Cochlear Implants A cochlear implant is a surgically implanted complex electronic device that helps overcome complications in the inner ear or cochlea. This implant consists of two major components: an external component known as the sound processor and an internal component known as the implant. The sound processor receives sound waves and processes them into detailed digital information. T …
- 血友病A(Hemophilia A)：世界の治験レビュー2014年下半期版Hemophilia A Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Hemophilia A Global Clinical Trials Review, H2, 2014" provides data on the Hemophilia A clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemophilia A. It includes an overview of the trial numbers and their recruitment status as per the sit …
- Testicular Cancer：グローバル臨床試験レビューH2, 2013Testicular Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H2, 2013" provides data on the Testicular Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Testicular Cancer. It includes an overview of the trial numbers and their recruitment s …
- 世界のPON （Passive Optical Network）装置市場動向（2014-2018）TechNavio’s analysts forecast the Global Passive Optical Network Equipment market will grow at a CAGR of 3.56 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing growth of PON equipment in the APAC region. The Global Passive Optical Network Equipment market has also been witnessing the development of ultra-high-capacity optical networks. H …
